[18F]MC225-PET in Neurodegenerative Disease

NCT05853471 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Neurodegenerative Diseases
Alzheimer Disease
Parkinson Disease
Mild Cognitive Impairment

Interventions

DRUG: [18F]MC225

Sponsor

University Medical Center Groningen